The implementation of genomic medicine across Australia doesn’t come without challenges. To best understand and address these challenges, we are undertaking research within four key programs:
- A national diagnostic and research network
- A national approach to data federation and analysis
- Economic analysis and policy implications for the health system
- Genomic workforce, education and ethics
The Cancer and Rare Disease Flagships are integrated within the research programs and are used as examples for system-wide implementation – providing access to patients to drive the networks and data collection for the programs, and in turn being supported by their infrastructure.
Our research is designed to provide evidence of clinical utility and cost effectiveness while embedding genomic medicine into the health system.
Our research is being performed within the health system, as part of healthcare delivery. This approach leads to faster translation of new knowledge within the system while increasing the research and implementation capacity of clinicians, and rapidly delivering benefits to patients.